BRUSSELS: The European Commission wants to speed up EU approval of experimental Covid-19 drugs, according to a document released by the EU executive on Thursday, with the aim of having at least three new medicines authorised by October.
The Commission did not clarify in the documents released on Thursday which drugs it could select for possible supply contracts, but other recent EU documents show that the EU executive has already been in talks with drugmakers developing monoclonal antibodies for possible procurement. Stella Kyriakides, the EU commissioner for health, said the new drugs should also help cure “long Covid”, a series of symptoms that affect Covid patients for months after the infection has gone.
The Ema has issued scientific advice on 57 Covid-19 therapeutics in development, including small molecules and monoclonal antibodies, antivirals and immunomodulators.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.